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a reduction of the ﬁnal tumor volume (p = 0.03) and an overexpression
of VASH (p = 0.03), but without affecting the vascular amount (p > 0.05).
When administered therapeutically, all the tested compounds were able
to inhibit tumor growth (p < 0.01), assuming that the Q3G group had
decreased ﬁnal tumor volume (p = 0.04) as well increased VASH expression
(p = 0.03) and decreased vascular proliferation (p < 0.05). It was found an
inversely proportional relationship between the tumor growth of human colon
adenocarcinoma/HT-29 and VASH expression (p < 0.05).
Conclusion: Flavonoids HR and Q3G demonstrated antiangiogenic potential
in colon adenocarcinoma/HT-29 when administered prophylactic and ther-
apeutically, respectively. Q3G showed direct inhibition of the neovascular
proliferation.
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Background: Natural combinatorial chemistry has been occurring in plants
and microorganisms throughout evolutionary history and consequently is
far more sophisticated than that achievable in the laboratory by current
combinatorial chemical procedures. This makes natural products an invaluable
source of novel bioactive molecules which could lead to the development of
novel pharmaceutical compounds to treat cancer.
Material and Methods: Samples were collected from Heysham, West
Lancashire. Marine bacteria were isolated to pure culture from marine tidal
surfaces including marine invertebrates, molluscs and marine plants using
actinomycete-seawater culture media. Resultant pure cultures were grown
in liquid media and cell-free crude extracts where prepared by culture
centrifugation and ﬁlter-sterilisation. Bacterial species were identiﬁed by 16S
rDNA PCR-sequencing methods. Crude extracts were then screened for
bioactivity in the human haematological cell lines (Jurkat, U937 and K562)
to determine their effects on cell proliferation, cell cycle and induction of
apoptosis.
Results and Discussion: From an initial pilot study of 12 extracts derived
from several strains of actinomycetes, 5/12 demonstrated anti-proliferative
properties for both 24 and 48 hour timepoints. A further extract demonstrated
anti-tumour activity at the 48 hour time point only.
Conclusion: The pilot study successfully investigated 12 extracts derived
from marine bacteria and had a high success rate (42% for both 24 and
48 hour time points, 50% for 24 hour and/or 48 hour timepoints). One of
the extracts demonstrated anti-proliferative properties that were more potent
than the hydroxyurea (positive) control. Evaluation of the bioactive properties
of the remaining panel of extracts (n = 82) is now underway. Marine bacteria
represent a largely untapped resource with enormous potential as a source of
novel bioactive compounds.
No conﬂict of interest.
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Background: Flavonoids are polyphenolic compounds widely distributed in
the plant kingdom, whose importance lies in its beneﬁcial physiological effects,
including antioxidant and anti-proliferative effects. Carcinogenesis is a complex
process that involves metabolic and cell proliferative changes by alteration in
organic circuits, including oncogenes and tumor suppressor genes such as
P53 and ING2.
Method: For the experiment, 25 athymic mice were used and randomly
divided into 5 groups: control, therapeutic Q3G and HR, prophylactic Q3G
and HR. All animals were implanted with colon adenocarcinome (HT-29)
tumor cell line under subcutaneous tissue. Control animals had their tumor
growth assessed and used as a standard curve for comparative analysis.
Prophylactic groups were gavados with their respective drugs for 7 days
prior to tumor implantation, while animals from therapeutic groups were
implanted and gavados only when their tumors reached volumes equal to
or greater than 100mm3. After an evaluation of tumor growth the animals
were euthanized, their tumors resected and stored for histological analysis
and immunohistochemistry. The mechanism of action of the compounds
was evaluated by immunohistochemical analysis of parafﬁn embedded tumor
pieces, investigating the expression of proteins that participate in cell regulation
process and progression of carcinogenesis, p53 and ING2. The analysis of the
results was carried out by adopting a signiﬁcance level of 5% (p 0.05).
Results and Discussion: Histological analysis showed poorly differentiated
adenocarcinoma with the presence of signet ring cell. There was a reduction
of tumor growth in all groups tested in the control group (p = 0.00).
Immunohistochemical analysis revealed a reduction in the expression of p53
(p = 0.00) in all groups compared to control group. There was no difference
in the expression of ING2 (p = 0.97). The drugs tested exhibited tumor
growth reduction and involvement in antiproliferative pathways mediated by
the p53 protein, corroborating literature data showing activation of apoptotic
mitochondrial pathway of ﬂavonoid.
Conclusions: Flavonoids Q3G and HR demonstrated antitumor activity.
Reduction of tumor growth was observed in all groups, moreover it was directly
proportional to the reduction in mutated p53 expression in the therapeutic Q3G
group (p = 0.03), indicating a potential pro-apoptotic action and cell cycle arrest
(G1 / S phase) through p53 signaling pathways.
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Flavonoids have shown biological effects, including antitumor activity by
cell cycle arrest, DNA repair and apoptosis induction. Quercetin-3-O-
glucoside (Q3G) has been the aim of several studies; however, it is scarce
in nature. Q3G can be obtained with enzymatic de-glycosylation of quercetin-
3-rutinoside (Rutin), resulting in a mixture addressed as Hydrolized Rutin (HR),
with signiﬁcant increase in bioavailability and antitumor potential. This study
sets out to evaluate HR’s cytotoxic activity in vitro, and its antiproliferative,
pro-oxidative and genotoxic potential in animal model of glioma/U-251.
Method: Tumor cell lines panel were evaluated for HR’s antiproliferative
activity using Sulforhodamine B assay. HR’s action mechanisms were also
investigated in cells apoptosis and cell cycle by ﬂow cytometry. 15 nude mice
randomly were divided in 3 groups: control (n = 7), HR treatment (n = 4) and HR
prophylaxis (n = 4). All animals were grafted with human Glioma/U-251. The
control group didn’t receive any treatment. The HR prophylaxis group received
the biocoumpond for 5 days prior to tumor graft, while the HR treatment group
ﬁrst received the graft, initiating coumpound administration only when tumors
reached volumes 100mm3. All animals had tumor growth daily monitored.
The control group was used as a standard for comparative analysis. The
animals were euthanized and the tumors ressected. The histopathological
analysis used to conﬁrm diagnosis, morphological characteristics, number of
mitosis and the presence of necrosis. Lipid peroxidation was done by TBARS
method and genotoxicity tests by COMET assay. The results were carried out
adopting a signiﬁcance level of 5%.
Results: Among the tumor cell lines tested, HR obtained the best
antiproliferative effect on Glioma/U251, able to reach signiﬁcant results of total
growth inhibition (TGI) with 3.6 mg/mL of drug concentration. No results were
found in apoptosis ﬂow cytometry. However, HR showed action of cell cycle
arrest in the G1 phase, demonstrating a cytostatic effect. There was tumor
growth inhibition on treated (p = 0.03) and prophylaxis group (p = 0.01). There
was a decrease in mitoses (p < 0.04) in the treated groups. There was an
increase in lipid peroxidation of both prophylactic and therapeutic HR groups.
There was no signiﬁcant variation in oxidative DNA damage level.
Conclusion: HR exhibited moderate antiproliferative action in glioma.
Cytoxicity was proven by TBARS assay; although, no genotoxic effect was
shown. The evaluation of possible action mechanisms of HR in glioblastoma
demonstrated cytostatic effect, but no apoptosis induction. Therefore, HR
presents antiproliferative effect in high grade glioma/U-251. Results suggest
that mitosis reduction and celular morphology changes are due to mechanisms
related to drug action through a process of apparent oxidative damage on the
cell membrane.
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Among the various types of cancers, glioma is conﬁgured as a neoplasm of
high power of invasion, proliferation and recurrence, being among the most
lethal human cancers. The average survival time is usually less than one year
after diagnosis. Thus, the need to search for new drug to combat this tumor
improves survival of patients. Flavonoids are phenolic compounds of natural
origin that are present in most foods of the human diet and have antitumor
activity.
